Edward Miller
General Counsel bei ALLOVIR, INC.
Vermögen: 386 580 $ am 31.03.2024
Profil
Edward Miller is currently working as the Secretary & General Counsel at AlloVir, Inc. Previously, he held the position of Director-Finance & Accounting at Eloxx Pharmaceuticals, Inc. From 2014 to 2017, he served as the Chief Compliance Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. Prior to that, he worked at Boehringer Ingelheim Corp.
as the Vice President & Associate General Counsel from 2000 to 2014.
Mr. Miller completed his undergraduate studies at Princeton University and obtained his graduate degree from Rutgers Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALLOVIR INC
0,45% | 22.04.2024 | 512 026 ( 0,45% ) | 386 580 $ | 31.03.2024 |
Aktive Positionen von Edward Miller
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLOVIR, INC. | General Counsel | 01.01.2019 |
Ehemalige bekannte Positionen von Edward Miller
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Compliance Officer | 01.05.2017 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | General Counsel | 01.01.2014 |
| ELOXX PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Ausbildung von Edward Miller
| Princeton University | Undergraduate Degree |
| Rutgers Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
